The prevalence of ALT is notably greater in certain cancer types, including sarcomas, isocitrate dehydrogenase-mutant astrocytoma (WHO grade II–IV), pancreatic neuroendocrine tumors, neuroblastoma and chromophobe hepatocellular carcinomas [4]. Here, GPT is linked to cancer.